BFM
ANVS icon

Boothbay Fund Management’s Annovis Bio ANVS Stock Holding History

Boothbay Fund Management’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-160,300
Closed -$923K – 1599
2024
Q2 		$923K Buy
160,300
+93,100
+139% +$755K 0.02% 748
2024
Q1 		$800K Buy
+67,200
New +$733K 0.02% 828

Other funds holding ANVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Boothbay Fund Management's ANVS Position: Q3 2021 in Review

Boothbay Fund Management sold out of Annovis Bio (ANVS) in Q3 2021, closing a stake of 11,756 shares — an estimated $1.01M sold.

Boothbay Fund Management first reported a position in ANVS in Q2 2020 and held it in 3 quarters. The position peaked at $1.01M in Q2 2021. 38 funds tracked by Wall St. Rank hold ANVS as of Q3 2021.

  • Boothbay Fund Management reported no remaining Annovis Bio position as of Q3 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 11,756 Annovis Bio shares in Q3 2021, an estimated $1.01M.
  • Boothbay Fund Management first reported a position in Annovis Bio in Q2 2020 and held it in 3 quarters.
  • Boothbay Fund Management's Annovis Bio position peaked at $1.01M in Q2 2021.
  • 38 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2021.

Based on Boothbay Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.